BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33345771)

  • 21. Discrete change in volatile anesthetic sensitivity in mice with inactivated tandem pore potassium ion channel TRESK.
    Chae YJ; Zhang J; Au P; Sabbadini M; Xie GX; Yost CS
    Anesthesiology; 2010 Dec; 113(6):1326-37. PubMed ID: 21042202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation.
    Schroeter CB; Nelke C; Schewe M; Spohler L; Herrmann AM; Müntefering T; Huntemann N; Kuzikov M; Gribbon P; Albrecht S; Bock S; Hundehege P; Neelsen LC; Baukrowitz T; Seebohm G; Wünsch B; Bittner S; Ruck T; Budde T; Meuth SG
    Biol Chem; 2023 Mar; 404(4):355-375. PubMed ID: 36774650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling of a tandem two pore domain potassium channel reveals a putative binding site for general anesthetics.
    Bertaccini EJ; Dickinson R; Trudell JR; Franks NP
    ACS Chem Neurosci; 2014 Dec; 5(12):1246-52. PubMed ID: 25340635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical probing of a dynamic membrane interaction that regulates the TREK1 channel.
    Sandoz G; Bell SC; Isacoff EY
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2605-10. PubMed ID: 21262820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of the anesthetic sensitivity of two-pore domain acid-sensitive potassium channels: molecular cloning of an anesthetic-activated potassium channel from Lymnaea stagnalis.
    Andres-Enguix I; Caley A; Yustos R; Schumacher MA; Spanu PD; Dickinson R; Maze M; Franks NP
    J Biol Chem; 2007 Jul; 282(29):20977-90. PubMed ID: 17548360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How ion channels sense mechanical force: insights from mechanosensitive K2P channels TRAAK, TREK1, and TREK2.
    Brohawn SG
    Ann N Y Acad Sci; 2015 Sep; 1352():20-32. PubMed ID: 26332952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of K2P 2.1 and K2P 10.1 K(+) channel sensitivity to carvedilol by alternative mRNA translation initiation.
    Kisselbach J; Seyler C; Schweizer PA; Gerstberger R; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2014 Dec; 171(23):5182-94. PubMed ID: 25168769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TREK1 activation mediates spinal cord ischemic tolerance induced by isoflurane preconditioning in rats.
    Yin X; Su B; Zhang H; Song W; Wu H; Chen X; Zhang X; Dong H; Xiong L
    Neurosci Lett; 2012 May; 515(2):115-20. PubMed ID: 22425721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiology and pharmacology of two-pore domain potassium channels.
    Kim D
    Curr Pharm Des; 2005; 11(21):2717-36. PubMed ID: 16101451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of volatile anesthetic isoflurane on ATP-sensitive K+ channels in rabbit ventricular myocytes.
    Han J; Kim E; Ho WK; Earm YE
    Biochem Biophys Res Commun; 1996 Dec; 229(3):852-6. PubMed ID: 8954983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal microRNAs modulate TREK two-pore domain K
    Paschou M; Maier L; Papazafiri P; Selescu T; Dedos SG; Babes A; Doxakis E
    RNA Biol; 2020 May; 17(5):651-662. PubMed ID: 31994436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent modification of a volatile anesthetic regulatory site activates TASK-3 (KCNK9) tandem-pore potassium channels.
    Conway KE; Cotten JF
    Mol Pharmacol; 2012 Mar; 81(3):393-400. PubMed ID: 22147752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoflurane exposure regulates the cell viability and BDNF expression of astrocytes via upregulation of TREK‑1.
    Zhou CH; Zhang YH; Xue F; Xue SS; Chen YC; Gu T; Peng ZW; Wang HN
    Mol Med Rep; 2017 Nov; 16(5):7305-7314. PubMed ID: 28944872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREK‑TRAAK two‑pore domain potassium channels protect human retinal pigment epithelium cells from oxidative stress.
    Huang H; Li H; Shi K; Wang L; Zhang X; Zhu X
    Int J Mol Med; 2018 Nov; 42(5):2584-2594. PubMed ID: 30106090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.
    Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
    Eur J Pharmacol; 2013 Dec; 721(1-3):237-48. PubMed ID: 24070813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K
    Lolicato M; Arrigoni C; Mori T; Sekioka Y; Bryant C; Clark KA; Minor DL
    Nature; 2017 Jul; 547(7663):364-368. PubMed ID: 28693035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological roles of heteromerization: focus on the two-pore domain potassium channels.
    Khoubza L; Chatelain FC; Feliciangeli S; Lesage F; Bichet D
    J Physiol; 2021 Feb; 599(4):1041-1055. PubMed ID: 33347640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterodimerization within the TREK channel subfamily produces a diverse family of highly regulated potassium channels.
    Levitz J; Royal P; Comoglio Y; Wdziekonski B; Schaub S; Clemens DM; Isacoff EY; Sandoz G
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4194-9. PubMed ID: 27035963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lower X-gate in TASK channels traps inhibitors within the vestibule.
    Rödström KEJ; Kiper AK; Zhang W; Rinné S; Pike ACW; Goldstein M; Conrad LJ; Delbeck M; Hahn MG; Meier H; Platzk M; Quigley A; Speedman D; Shrestha L; Mukhopadhyay SMM; Burgess-Brown NA; Tucker SJ; Müller T; Decher N; Carpenter EP
    Nature; 2020 Jun; 582(7812):443-447. PubMed ID: 32499642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein complex analysis of native brain potassium channels by proteomics.
    Sandoz G; Lesage F
    Methods Mol Biol; 2008; 491():113-23. PubMed ID: 18998088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.